SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-14-002848
Filing Date
2014-09-05
Accepted
2014-09-04 21:20:20
Documents
3
Period of Report
2014-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm 8-K 33555
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 17510
3 GRAPHIC image_001.jpg GRAPHIC 6286
  Complete submission text file 0001493152-14-002848.txt   61164
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 141084405
SIC: 2834 Pharmaceutical Preparations